top of page
News, Events and Updates
Search
Anavex Life Sciences Presents New Clinical Data Identifying Gut Microbiota Biomarkers
Jul 16, 2019
Anavex Life Sciences Announces First Patient Dosed in U.S. Phase 2 Clinical Trial of ANAVEX®2-73
Jun 24, 2019
Anavex Life Sciences Announces First Patient Dosed in Phase 2 Clinical Trial of ANAVEX®2-73
Jun 5, 2019
Anavex Life Sciences Reports Fiscal 2019 Second Quarter Financial Results, Updates on Clinical Study
May 7, 2019
Rett Syndrome Association of Australia and Anavex Life Sciences Initiate Phase 2 AVATAR Study
May 7, 2019
Anavex Life Sciences to Announce Fiscal 2019 Second Quarter Financial Results on Wednesday, 5/8/2019
May 5, 2019
Anavex Life Sciences to Present at the H.C. Wainwright Annual Global Life Sciences Conference
Apr 4, 2019
Anavex Life Sciences Presents Data On ANAVEX®2-73 in Alzheimer’s Disease at the ASENT 2019 Meeting
Mar 27, 2019
Anavex Life Sciences Announces First Patient Dosed in Phase 2 Clinical Trial of ANAVEX®2-73
Mar 17, 2019
Anavex Life Sciences to Present at the 31st Annual ROTH Conference 2019
Mar 12, 2019
Anavex Life Sciences Reaches 50% Enrollment Threshold in ANAVEX®2-73 PDD Study Ahead of Schedule
Mar 10, 2019
19
20
21
22
23
Stay Connected
Follow us on social media
Newsroom
Webcast Library
Contact Us
Back to Newsroom
bottom of page
